Y
Yosuke Kishimoto
Researcher at Tottori University
Publications - 44
Citations - 1396
Yosuke Kishimoto is an academic researcher from Tottori University. The author has contributed to research in topics: Hepatocellular carcinoma & Loss of heterozygosity. The author has an hindex of 22, co-authored 44 publications receiving 1366 citations.
Papers
More filters
Journal ArticleDOI
A new gastric ulcer model induced by ischemia-reperfusion in the rat: Role of leukocytes on ulceration in rat stomach
Kouichirou Wada,Yoshinori Kamisaki,Masayuki Kitano,Yosuke Kishimoto,Kentaro Nakamoto,Tadao Itoh +5 more
TL;DR: Results indicate that in this model, gastric acid together with leukocytes contribute to the development of ulcers following erosions, and a combination of omeprazol and pentoxifylline was more effective than either drug alone.
Journal ArticleDOI
Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer
Norimasa Miura,Hiroshige Nakamura,Reina Sato,Tomoe Tsukamoto,Tomomi Harada,Shunsaku Takahashi,Youshin Adachi,Kohei Shomori,Akiko Sano,Yosuke Kishimoto,Hisao Ito,Junichi Hasegawa,Goshi Shiota +12 more
TL;DR: The data suggest that hTERT mRNA, especially when combined with EGFR mRNA, is a novel and excellent biomarker for pulmonary malignancies to diagnose and assess the clinical stage.
Journal ArticleDOI
Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography
Yoshinori Kamisaki,Kouichirou Wada,Kentaro Nakamoto,Yosuke Kishimoto,Masayuki Kitano,Tadao Itoh +5 more
TL;DR: Since 3-nitrotyrosine is a stable product of peroxynitrite, an oxidant formed by a reaction of nitric oxide and superoxide radicals, the measurement of its plasma concentration may be useful as a marker of nitrics oxide-dependent oxidative damage.
Journal ArticleDOI
Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
Tomokazu Ohishi,Yosuke Kishimoto,Norimasa Miura,Goshi Shiota,Toshiyuki Kohri,Yukihiko Hara,Junichi Hasegawa,Mamoru Isemura +7 more
TL;DR: EGCG with sulindac synergistically suppresses ACF formation by enhancing apoptosis and, therefore, that EGCG is a suitable candidate for use in combination with cancer-preventive agents, such as sulindAC, to reduce their adverse effects.
Journal ArticleDOI
Serum Human Telomerase Reverse Transcriptase Messenger RNA as a Novel Tumor Marker for Hepatocellular Carcinoma
Norimasa Miura,Yoshiko Maeda,Takamasa Kanbe,Hiroaki Yazama,Yohei Takeda,Reina Sato,Tomoe Tsukamoto,Emi Sato,Akira Marumoto,Tomomi Harada,Akiko Sano,Yosuke Kishimoto,Yasuaki Hirooka,Yoshikazu Murawaki,Junichi Hasegawa,Goshi Shiota +15 more
TL;DR: Serum hTERT mRNA showed higher values in patients with HCC than those with chronic liver diseases, and proved to be superior to AFP mRNA, AFP, and des-γ-carboxy prothrombin in HCC diagnosis and its superiority to conventional tumor markers were shown.